Species
Species:
Trichostrongylus affinis
Trichostrongylus andreevi Grigorian, 1952
Trichostrongylus askivali Dunn, 1964
Trichostrongylus axei (Cobbold, 1879)
Trichostrongylus brevis Otsuru, 1962
Trichostrongylus calcaratus Ransom, 1911
Trichostrongylus capricola Ransom, 1907
Trichostrongylus colubriformis (Giles, 1892)
Trichostrongylus duretteae Rossin, Timi & Malizia, 2006
Trichostrongylus lerouxi Biocca, Chabaud & Ghadirian, 1974
Trichostrongylus longispicularis Gordon, 1933
Trichostrongylus medius Oliger, 1950
Trichostrongylus ostertagiaeformis Kadenazii, 1957
Trichostrongylus pietersei Le Roux, 1932
Trichostrongylus probolurus (Railliet, 1896)
Trichostrongylus retortaeformis (Zeder, 1800)
Trichostrongylus sigmodontis
Trichostrongylus skrjabini Kalantarian, 1928
Trichostrongylus suis Iwanitzki, 1930
Trichostrongylus tenuis (Mehlis, 1846)
Trichostrongylus ventricosus (Rudolphi, 1809)
Trichostrongylus vitrinus Looss, 1905


== References ==
If no response is seen or if inducers of caspofungin clearance (see above) are coadministered the daily dose may be increased to 70 mg. An infusion should take approximately 1 hour. Dosage forms
Cancidas 50 mg for intravenous infusion (manufacturer Merck)
Cancidas 70 mg for intravenous infusion (manufacturer Merck)
Brand names in countries other than the U.S. may vary. Semisynthesis
Caspofungin is semisynthesized from pneumocandin B0, a fermentation product of Glarea lozoyensis. References
External links
"Caspofungin". Drug Information Portal. U.S. National Library of Medicine. U.S. Full Prescribing Information
EMA on Cancidas (Summary of Product Characteristics)